Replies to post #859 on Ampio Pharmaceuticals Inc (AMPE)

[TJG]

Soon as we get the results from the granted IND that the FDA gave us after the tests below were admitted this will go way up

The FDA requested comprehensive tests on the safety of nebulized Ampion at various doses. The results of these tests have been reviewed by independent toxicologists who found no evidence of toxicity in preclinical trials, even at extreme doses, and this extensive data has been submitted to the FDA.Aug 19, 2020

https://ampiopharma.com/news/ampio-provides-update-on-covid-19-clinical-trial-activities/#:~:text=The%20FDA%20requested%20comprehensive%20tests,been%20submitted%20to%20the%20FDA.

FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress
Date: September 21, 2020 | READ MORE >